Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]
Sign Up To Get Our Instant Alerts!
- JPMorgan Bringing Back Employees to Work From Office 434 views
- Apple Employee Claims to Have Been Dismissed After Leading Movement Against Harassment 317 views
- Spotify Records 20% Increase in Paid Subscribers in the Second Quarter 305 views
- Solar Car Company Sono Motors Files For United States IPO 248 views
- Ferari Poaches New CEO From Tech Industry 237 views